Review Article
The anticholinergic burden and antipsychotics: Outlook on new drugs in the pipeline
VM Aziz, MD, FRCPSYCH, MBBCB*; Tony Aziz, MPharm
In addition to their affinity for D2 dopaminergic receptors, antipsychotic drugs prescribed for the treatment of psychotic disorders frequently exhibit anticholinergic side effects. Central M1, M4, or dual M1/M4 receptor agonists are among the current class of mAChR agonists that target psychosis....